MA26790A1 - Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie - Google Patents

Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie

Info

Publication number
MA26790A1
MA26790A1 MA26402A MA26402A MA26790A1 MA 26790 A1 MA26790 A1 MA 26790A1 MA 26402 A MA26402 A MA 26402A MA 26402 A MA26402 A MA 26402A MA 26790 A1 MA26790 A1 MA 26790A1
Authority
MA
Morocco
Prior art keywords
oxaluria
dietetic
hyper
prevention
treatment
Prior art date
Application number
MA26402A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Vsl Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vsl Pharma Ltd filed Critical Vsl Pharma Ltd
Publication of MA26790A1 publication Critical patent/MA26790A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/04Drugs for disorders of the urinary system for urolithiasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA26402A 1999-05-28 2001-11-08 Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie MA26790A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999RM000338A IT1309427B1 (it) 1999-05-28 1999-05-28 Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso

Publications (1)

Publication Number Publication Date
MA26790A1 true MA26790A1 (fr) 2004-12-20

Family

ID=11406789

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26402A MA26790A1 (fr) 1999-05-28 2001-11-08 Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie

Country Status (34)

Country Link
US (2) US6562336B2 (fr)
EP (1) EP1181027B1 (fr)
JP (1) JP4737836B2 (fr)
KR (1) KR100781703B1 (fr)
CN (1) CN100350919C (fr)
AR (1) AR024555A1 (fr)
AT (1) ATE265857T1 (fr)
AU (1) AU773459B2 (fr)
BR (1) BR0011038B1 (fr)
CA (1) CA2373255C (fr)
CZ (1) CZ20014076A3 (fr)
DE (1) DE60010456T2 (fr)
DK (1) DK1181027T3 (fr)
DZ (1) DZ3165A1 (fr)
EA (1) EA004257B1 (fr)
EE (1) EE200100618A (fr)
ES (1) ES2219344T3 (fr)
HK (1) HK1048066B (fr)
HU (1) HU225134B1 (fr)
IL (3) IL146703A0 (fr)
IS (1) IS6150A (fr)
IT (1) IT1309427B1 (fr)
MA (1) MA26790A1 (fr)
MX (1) MXPA01012184A (fr)
NO (1) NO20015782L (fr)
NZ (1) NZ516020A (fr)
PL (1) PL352014A1 (fr)
PT (1) PT1181027E (fr)
SI (1) SI1181027T1 (fr)
SK (1) SK16612001A3 (fr)
TR (1) TR200103439T2 (fr)
UA (1) UA71621C2 (fr)
WO (1) WO2000072855A2 (fr)
ZA (1) ZA200110504B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
JPWO2004112809A1 (ja) * 2003-06-24 2006-07-20 大塚製薬株式会社 血清尿酸低減組成物
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
AU2005224162A1 (en) 2004-03-19 2005-09-29 Danisco A/S Emulsifier composition for shortening
US7468182B2 (en) * 2004-10-27 2008-12-23 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
WO2006130187A1 (fr) 2005-05-31 2006-12-07 The Iams Company Lactobacilli felins a activite probiotique
BRPI0611492B1 (pt) 2005-05-31 2021-10-13 Mars, Incorporated Bifidobactéria probiótica felina
EP1962873B1 (fr) 2005-12-14 2013-05-29 OxThera, Inc., Compositions pharmaceutiques à base de bacteries redusiant l'oxalate
CN104013581A (zh) * 2005-12-16 2014-09-03 奥克斯赛拉公司 用于减少草酸和/或其盐的组合物和方法
AU2008230747A1 (en) * 2007-03-27 2008-10-02 The Procter & Gamble Company Methods and kits for administering probiotics
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CN101606952B (zh) * 2008-06-17 2012-09-19 上海交通大学医学院附属第三人民医院 乳双歧杆菌在制备预防泌尿***结石药物中的应用
JP5632289B2 (ja) 2008-09-30 2014-11-26 株式会社明治 高いシュウ酸分解能を有する乳酸菌
CN101554237B (zh) * 2009-03-16 2013-11-06 武汉康复得生物科技有限公司 植物纤维或微生物不溶组分中的草酸降解酶的制备方法
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20121173A1 (it) * 2012-07-04 2014-01-05 Neupharma Srl Composizioni dietetiche e/o farmaceutiche comprendenti ceppi di lactobacillus e bifidobacterium capaci di degradare gli ossalati e di indurre una risposta immunitaria di tipo anti-infiammatorio
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
JP5765832B2 (ja) * 2013-12-26 2015-08-19 雪印メグミルク株式会社 加齢に伴う代謝異常症の予防・改善・治療剤
ES2808677T3 (es) * 2014-10-01 2021-03-01 Triphase Pharmaceuticals Pvt Ltd Cepas termoestables, productos y métodos de las mismas
ITUB20155752A1 (it) * 2015-11-19 2017-05-19 Probiotical Spa Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli.
CN107868776A (zh) 2016-09-23 2018-04-03 武汉康复得生物科技股份有限公司 糖基化草酸脱羧酶及其制备和应用
US11179426B2 (en) 2016-12-29 2021-11-23 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
WO2020123483A1 (fr) * 2018-12-10 2020-06-18 Novome Biotechnologies, Inc. Méthodes et compositions pour le traitement de l'hyperoxalurie
CN113308416B (zh) * 2021-07-20 2023-02-24 四川大学 一株具有抑制肾结石形成能力的植物乳杆菌及其应用
CN115851508B (zh) * 2022-10-13 2024-01-09 山东中科嘉亿生物工程有限公司 一种降草酸、改善肾结石的嗜热链球菌jyst-26及其产品、应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5810520A (ja) * 1981-07-10 1983-01-21 Miyarisan Kk 胆石症の治療薬
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
EP0856259B1 (fr) * 1996-12-23 1998-08-12 SITIA-YOMO S.p.A. Composition pour l'usage dans l'alimentation comprenant de bactéries vivantes lactiques lyophisées
KR20010012845A (ko) * 1997-05-23 2001-02-26 아익션 바이오테크놀로지, 인코퍼레이티드 옥살산염 관련 질병의 예방을 위한 옥살산염-분해 미생물또는 옥살산염-분해 효소
RU2139346C1 (ru) * 1999-03-02 1999-10-10 Шендеров Борис Аркадьевич Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для приготовления препаратов и продуктов питания для профилактики и лечения гипероксалурии

Also Published As

Publication number Publication date
IT1309427B1 (it) 2002-01-23
JP4737836B2 (ja) 2011-08-03
EP1181027A2 (fr) 2002-02-27
AR024555A1 (es) 2002-10-16
UA71621C2 (en) 2004-12-15
IL199437A (en) 2016-10-31
KR100781703B1 (ko) 2007-12-03
HK1048066B (zh) 2008-08-01
ITRM990338A1 (it) 2000-11-28
DE60010456D1 (de) 2004-06-09
WO2000072855A2 (fr) 2000-12-07
SI1181027T1 (en) 2004-08-31
HUP0201409A2 (en) 2002-08-28
AU5101600A (en) 2000-12-18
CZ20014076A3 (cs) 2002-03-13
BR0011038A (pt) 2002-02-26
AU773459B2 (en) 2004-05-27
BR0011038B1 (pt) 2014-02-18
ITRM990338A0 (it) 1999-05-28
HK1048066A1 (en) 2003-03-21
HUP0201409A3 (en) 2004-10-28
TR200103439T2 (tr) 2002-06-21
EE200100618A (et) 2003-02-17
NZ516020A (en) 2003-06-30
ATE265857T1 (de) 2004-05-15
CA2373255C (fr) 2010-01-19
JP2003500451A (ja) 2003-01-07
USRE39585E1 (en) 2007-04-24
IL146703A (en) 2010-03-28
EA200101262A1 (ru) 2002-04-25
EA004257B1 (ru) 2004-02-26
KR20020019918A (ko) 2002-03-13
CN100350919C (zh) 2007-11-28
IL199437A0 (en) 2011-07-31
US20020061292A1 (en) 2002-05-23
DE60010456T2 (de) 2005-05-12
MXPA01012184A (es) 2003-06-30
DZ3165A1 (fr) 2000-12-07
PT1181027E (pt) 2004-09-30
NO20015782L (no) 2002-01-25
NO20015782D0 (no) 2001-11-27
US6562336B2 (en) 2003-05-13
DK1181027T3 (da) 2004-08-16
PL352014A1 (en) 2003-07-14
IL146703A0 (en) 2002-07-25
CN1365284A (zh) 2002-08-21
HU225134B1 (en) 2006-06-28
IS6150A (is) 2001-11-08
ES2219344T3 (es) 2004-12-01
WO2000072855A3 (fr) 2001-06-28
CA2373255A1 (fr) 2000-12-07
EP1181027B1 (fr) 2004-05-06
ZA200110504B (en) 2002-09-25
SK16612001A3 (sk) 2002-04-04

Similar Documents

Publication Publication Date Title
MA26790A1 (fr) Composition dietetique ou pharmaceutique a l'usage pour la prevention ou le traitement de la hyper-oxalurie
IL205298A0 (en) Pharmaceutical compositions comprising an antibody to ab and uses thereof in the prevention or treatment of a disease characterized by amyloid deposit
HUP0103654A2 (hu) Szmilagenin és/vagy anzurogenin-D alkalmazása Alzheimer-kór kezelésére szolgáló gyógyszerkészítmény előállítására
IL122733A0 (en) Pharmaceutical compositions for use in the treatment of allergic asthma
DZ2675A1 (fr) Association pharmaceutique pour le traitement d'undysfunctionnement sexuel et compositions la conte nant.
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
FR2812197B1 (fr) Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
FR2742657B1 (fr) Compositions pour le traitement des matieres keratiniques contenant l'association d'un polymere polyampholyte et d'un polymere cationique
FR2792835B3 (fr) Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
FR2717080B1 (fr) Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales.
FR2746658B1 (fr) Valve de drainage implantable pour le traitement de l'hydrocephalie
FR2741355B1 (fr) Composition pour le traitement d'objets que l'on souhaite nettoyer et/ou desinfecter
FR2758465B1 (fr) Composition pour le traitement de l'amiante
DZ1988A1 (fr) Thérapie de combinaison pour le traitement de l'hiv.
FR2744361B1 (fr) Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
DZ2564A1 (fr) Compositions pharmaceutiques pour le traitement dudiabète sucre et d'états associés.
DZ3320A1 (fr) Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine
FR2786096B1 (fr) Composition pour la prevention et le traitement topique de la cellulite
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2792199B3 (fr) Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
FR2720944B1 (fr) Composition thérapeutique ou diététique sous forme de gel médicamenteux pour l'administration à des animaux de compagnie.
FR2774289B1 (fr) Medicament pour le traitement des dereglements de l'apoptose
FR2751637B1 (fr) Cellule d'electrocoagulation pour le traitement d'effluents
FR2751544B1 (fr) Composition therapeutique pour le traitement des verrues vulgaires
FR2826261B1 (fr) Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche